Exploring access to medicinal cannabis through general practitioners in Australia

Patient access to medicinal cannabis (MC) is impacted by several factors, despite legalisation of it for medicinal and related scientific purposes in 2016. This scoping review aimed to examine the barriers and enablers to accessing MC through general practitioners (GPs) in Australia.

Access here

Previous
Previous

Deb Ranson and Sally-Anne Jones: The Great Leap Forward – Where to Next?

Next
Next

DANA Conference | 2023